Suppr超能文献

溶剂/去污剂处理的人血浆和检疫新鲜冰冻血浆的体外特性研究

In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma.

作者信息

Beeck H, Hellstern P

机构信息

Institut für Hämostaseologie und Transfusionsmedizin, Klinikum Ludwigshafen, Germany.

出版信息

Vox Sang. 1998;74 Suppl 1:219-23. doi: 10.1111/j.1423-0410.1998.tb05476.x.

Abstract

BACKGROUND AND OBJECTIVES

Plasma pools, solvent/detergent(S/D)-treated plasma produced from plasma pools, and single donor fresh frozen plasma that had been quarantined for at least 6 months (QFFP) differ in their composition regarding clotting factors, inhibitors and other important plasma proteins. There are poor data concerning stability of important clotting factors after thawing of frozen plasma units.

MATERIALS AND METHODS

12 plasma pools, 12 batches of S/D plasma produced from these respective plasma pools, and 12 units of QFFP were extensively analysed. The stability of fibrinogen and factors V, VII, and VIII after thawing, storage at room temperature and at +4 degrees C was also examined.

RESULTS

We extensively analysed plasma pools before and after solvent/detergent treatment as well as quarantined single donor plasma units for parameters of coagulation and fibrinolysis. After the S/D step, all clotting factor activities and the activities of most inhibitors and other plasma proteins were in the normal range in all batches. Protein S and plasmin inhibitor activities decreased by 35% and 76%, respectively. S/D treatment partly activated factor VII (FVII). However, there were no marked increases of other markers of activated hemostasis. The interindividual variations of all proteins analysed were significantly lower in the S/D plasmas than in the single donor plasma units. An 8-hour storage lead to a marked decrease of FVIII activity, whereas there was no significant influence on fibrinogen and factors V and VII.

CONCLUSIONS

There are no critical reductions of the activities of clotting factors, inhibitors, and other important plasma proteins due to S/D treatment. Efficacy and safety of S/D plasma is not hampered by reduced activities of protein S and plasmin inhibitor. Dosage calculation and the evaluation of clinical response is simplified by usage of the more standardized S/D plasma compared to QFFP.

摘要

背景与目的

血浆库、由血浆库制备的经溶剂/去污剂(S/D)处理的血浆以及已隔离至少6个月的单采新鲜冰冻血浆(QFFP)在凝血因子、抑制剂及其他重要血浆蛋白的组成方面存在差异。关于冰冻血浆单位解冻后重要凝血因子稳定性的数据较少。

材料与方法

对12个血浆库、由这些血浆库各自制备的12批S/D处理血浆以及12单位QFFP进行了广泛分析。还检测了纤维蛋白原以及因子V、VII和VIII在解冻后、室温及4℃储存后的稳定性。

结果

我们对溶剂/去污剂处理前后的血浆库以及隔离的单采血浆单位的凝血和纤溶参数进行了广泛分析。经过S/D处理步骤后,所有批次中所有凝血因子活性以及大多数抑制剂和其他血浆蛋白的活性均在正常范围内。蛋白S和纤溶酶抑制剂活性分别下降了35%和76%。S/D处理部分激活了因子VII(FVII)。然而,其他活化止血标志物没有明显增加。在S/D处理血浆中,所有分析蛋白的个体间差异显著低于单采血浆单位。8小时的储存导致FVIII活性显著下降,而对纤维蛋白原以及因子V和VII没有显著影响。

结论

S/D处理不会导致凝血因子、抑制剂及其他重要血浆蛋白的活性出现严重降低。蛋白S和纤溶酶抑制剂活性降低不会妨碍S/D处理血浆的有效性和安全性。与QFFP相比,使用更标准化的S/D处理血浆简化了剂量计算和临床反应评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验